AbbVie Inc’s (NYSE:ABBV) chief executive said on Friday the company’s new hepatitis C treatment Viekira Pak has the potential to capture a “meaningful share” of the U.S. market, where it is competing against Gilead Sciences (GILD.O). On Friday shares of AbbVie Inc. (NYSE:ABBV) closed at $60.35. Company’s EPS growth for next 5 years is recorded as 15.40%.
Pixelworks, Inc. (NASDAQ: PXLW), will release its fourth quarter and fiscal 2014 financial results on Thursday, February 5, 2015 after market close. Pixelworks, Inc. (NASDAQ:PXLW) in last trading activity increased 8.96% to close at $5.23. Company weekly performance is 9.87% while its quarterly performance stands at -8.73%. Pixelworks, Inc. (NASDAQ:PXLW) is -46.80% away from its 52 week high.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) on 21st January announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr. Bizzari brings extensive experience in oncology drug development. On last trading day Halozyme Therapeutics, Inc. (NASDAQ:HALO) decreased -2.12% to close at $14.28. Its volatility for the week is 5.21% while volatility for the month is 7.30%. HALO’s sales growth for past 5 years was 44.20% and its EPS growth for past 5 years was -3.90%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) monthly performance is 51.91%.
Corium International, Inc. (NASDAQ:CORI), announced that Peter Staple, Corium’s President and Chief Executive Officer, will present at the 2015 Leerink Global Healthcare Conference, Wednesday, February 11, 2015 at the Waldorf Astoria New York hotel. Corium International, Inc. (NASDAQ:CORI) has 0.10% insider ownership while its institutional ownership stands at 87.50%. In last trading activity company’s stock closed at $6.50.
Global Partners LP (NYSE:GLP) will begin trading ex-dividend on February 02, 2015. A cash dividend payment of $0.665 per share is scheduled to be paid on February 13, 2015. On last trading day Global Partners LP (NYSE:GLP) decreased -1.43% to close at $38.51. Its volatility for the week is 3.38% while volatility for the month is 3.67%. GLP’s sales growth for past 5 years was 16.80% and its EPS growth for past 5 years was -2.00%. Global Partners LP (NYSE:GLP) monthly performance is 14.96%.